BioNTech News

BioNTech | SC 13D: Statement of acquisition of beneficial ownership by individuals-BioNTech SE(12.5%)

Feb 22 06:07

BioNTech | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Prof. Ugur Sahin, M.D.(17.4%),Medine GmbH(17.0%)

Feb 14 20:31

BioNTech | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-ATHOS KG(43.8%),AT Impf GmbH(43.8%), etc.

Feb 8 06:08

BioNTech | SC 13G/A: Statement of acquisition of beneficial ownership by individuals(Amendment)-Prof. Ugur Sahin, M.D.(17.4%),Medine GmbH(17.0%)

Feb 22, 2023 08:17

BioNTech | SC 13G/A: Statement of acquisition of beneficial ownership by individuals(Amendment)-AT Impf GmbH(43.5%),Thomas Maier(43.5%), etc.

Feb 14, 2023 19:06

BioNTech | D: Filing D

Apr 14, 2022 23:11

BioNTech | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Medine GmbH(17.11%),Prof. Ugur Sahin, M.D.(17.11%)

Feb 15, 2022 05:23

BioNTech | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-ATHOS KG(43.8%),AT Impf GmbH(43.8%), etc.

Feb 12, 2022 06:01

BioNTech | SC 13G/A: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions (Amendment)

Feb 17, 2021 05:06

BioNTech | SC 13G/A: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions (Amendment)

Feb 17, 2021 05:00

BioNTech | SC 13G/A: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions (Amendment)

Feb 16, 2021 19:21

BioNTech | D: Filing D

Sep 17, 2020 20:26

BioNTech | SC 13G: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions

Feb 15, 2020 03:11

BioNTech | SC 13G: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions

Feb 14, 2020 01:53

BioNTech | SC 13G: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions

Feb 13, 2020 05:17

BioNTech | SC 13D: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities

Jan 24, 2020 05:01